Skip to main content
logo
Rakovina Therapeutics Inc. (TSXV:RKV)
Canada flag Canada · Delayed Price · Currency is CAD
0.2250
-0.0050 (-2.17%)
Oct 9, 2026, 12:47 PM EST

Rakovina Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1022761315
Market Cap Growth
63.58%-92.08%348.09%-52.61%-18.16%-
Enterprise Value
1342861112
Last Close Price
0.230.101.900.851.802.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.22----
PB Ratio
-4.6015.146.211.632.091.80
P/TBV Ratio
--83.04-13.065.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.6818.580.330.36--
Net Debt / Equity Ratio
-1.5816.450.030.25-0.15-0.33
Net Debt / EBITDA Ratio
-0.59-0.30-0.03-0.460.391.36
Quick Ratio
0.100.120.722.958.5225.32
Current Ratio
0.150.271.174.099.9926.94
Return on Equity (ROE)
-1352.29%-391.14%-102.34%-54.02%-38.35%-129.24%
Return on Assets (ROA)
-79.62%-98.84%-41.58%-27.53%-23.83%-35.72%
Return on Capital Employed (ROCE)
-619.90%-642.10%-88.10%-49.70%-46.90%-29.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-69.83%-410.47%-15.26%-43.86%-22.21%-35.95%
Buyback Yield / Dilution
-81.77%-119.25%-18.18%-0.03%-30.22%-